Brief: Compass Pathways Commends White House Executive Order To Accelerate Research And Access For Psychedelic Treatments
18/04/2026 21:33
April 18 (Reuters) - Compass Pathways PLC CMPS.O: COMPASS PATHWAYS COMMENDS WHITE HOUSE EXECUTIVE ORDER TO ACCELERATE RESEARCH AND ACCESS FOR PSYCHEDELIC TREATMENTS COMPASS PATHWAYS PLC - WELCOMES WHITE HOUSE EXECUTIVE ORDER ON ACCELERATING MEDICAL TREATMENTS COMPASS PATHWAYS PLC - ALREADY WORKING WITH FDA ON ROLLING SUBMISSION FOR COMP360 IN TREATMENT-RESISTANT DEPRESSION Source text: ID:nBw2djbffa Further company coverage: CMPS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on COMPASS Pathways
See all newsCompass Pathways PLC reports results for the quarter ended September 30 - Earnings Summary
Corrected: Compass Pathways Q3 net loss narrows on lower R&D charges
Corrected: BRIEF-COMPASS Pathways Q3 EPS USD -0.31
Psychedelic drug developers fall after Usona submits depressive drug application
Compass Pathways PLC expected to post a loss of 45 cents a share - Earnings Preview